Osteoporosis, Age-Related
9
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men
Bone Mineral Density and Bone Metabolism in Older Women
A Culinary Intervention for Bone Health
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Tart Cherry Supplementation and Women's Bone Health Study
Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism
Teriparatide for Fracture Repair in Humans